CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Tumor-infiltrating CD8+ T cells are strongly associated with patient survival in a wide variety of human cancers. Less is known about tumor-infiltrating CD20+ B cells, which often colocalize with T cells, sometimes forming organized lymphoid structures. In autoimmunity and organ transplantation, T cells and B cells collaborate to generate potent, unrelenting immune responses that can result in extensive tissue damage and organ rejection. In these settings, B cells enhance T cell responses by producing Abs, stimulatory cytokines, and chemokines, serving as local APCs, and organizing the formation of tertiary lymphoid structures that sustain long-term immunity. Thus, B cells are an important component of immunological circuits associated with persistent, rampant tissue destruction. Engagement of tumor-reactive B cells may be an important condition for generating potent, long-term T cell responses against cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
(2016) · Lung Transplantation · doi:10.3109/9781439802571-25 · Cited by 2,157
Immune infiltration in human tumors: a prognostic factor that should not be ignored
Pagès, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautès-Fridman, C., & Fridman, W.-H. (2010) · Oncogene · doi:10.1038/onc.2009.416 · Cited by 1,087
Dieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0284 · Cited by 1,031
Reciprocal regulation of polarized cytokine production by effector B and T cells
Harris, D. P., Haynes, L., Sayles, P. C., Duso, D. K., Eaton, S. M., Lepak, N. M., Johnson, L. L., Swain, S. L., & Lund, F. E. (2000) · Nature Immunology · doi:10.1038/82717 · Cited by 839
The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
Schmidt, M., Böhm, D., von Törne, C., Steiner, E., Puhl, A., Pilch, H., Lehr, H.-A., Hengstler, J. G., Kölbl, H., & Gehrmann, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5206 · Cited by 836
Lymphoid organ development: from ontogeny to neogenesis
Drayton, D. L., Liao, S., Mounzer, R. H., & Ruddle, N. H. (2006) · Nature Immunology · doi:10.1038/ni1330 · Cited by 776
Molecular Heterogeneity in Acute Renal Allograft Rejection Identified by DNA Microarray Profiling
Sarwal, M., Chua, M.-S., Kambham, N., Hsieh, S.-C., Satterwhite, T., Masek, M., & Salvatierra, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035588 · Cited by 701
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Ammirante, M., Luo, J.-L., Grivennikov, S., Nedospasov, S., & Karin, M. (2010) · Nature · doi:10.1038/nature08782 · Cited by 639
Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer
Al-Shibli, K. I., Donnem, T., Al-Saad, S., Persson, M., Bremnes, R. M., & Busund, L.-T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0133 · Cited by 614
Cytokine-producing B lymphocytes-key regulators of immunity
Lund, F. E. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.003 · Cited by 556
Cited by
Items 301–400 of 461
Ferrara, G., & Stefanato, C. M. (2013) · Journal of Cutaneous Pathology · doi:10.1111/cup.12141 · Cited by 7
Zaakouk, M., Longworth, A., Hunter, K. J., Jiman, S., Kearns, D., El-Deftar, M. M., & Shaaban, A. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126501 · Cited by 6
The lymphocytic inflammation correlates with metastatic risk in carcinoid tumours
Roncati, L., Manenti, A., Pusiol, T., Piscioli, F., & Barbolini, G. (2015) · Inflammation and Cell Signaling · doi:10.14800/ics.1049 · Cited by 6
Caro, G. D., Marchesi, F., Galdiero, M. R., & Grizzi, F. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.900443 · Cited by 6
Nathan, N., Paparoditis, P., Sarusi-Portuguez, A., Stoler‐Barak, L., Horn, H. M., Milo, I., Mazor, R. D., Levy‐Barda, A., Yanichkin, N., Borcherding, N., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.04.017 · Cited by 5
Can B- cell based immunotherapy be our new perspective to exit cancer?
Thomas, A., & Smitha, T. V. (2020) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_121_20 · Cited by 5
Ren, H., Wang, Z., Zhang, L., Zhu, G., Li, F., & Chen, B. (2024) · BMC Cancer · doi:10.1186/s12885-024-12114-y · Cited by 6
Qendro, V., Lundgren, D. H., Palczewski, S., Hegde, P., Stevenson, C. E., Perpetua, L., Latifi, A., Merriman, J., Bugos, G., & Han, D. K. M. (2017) · PROTEOMICS · doi:10.1002/pmic.201600318 · Cited by 5
Ligeiro, D., Rao, M., Maia, A., Castillo-Martín, M., López-Beltrán, A., & Maeurer, M. J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49270-0_10 · Cited by 5
Immune Microenvironment in Breast Cancer Metastasis
Qian, B., & Ma, R. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-70875-6_20 · Cited by 5
Mesocolic micro-skip metastasis
Bonetti, L. R., Manenti, A., Domati, F., & Farinetti, A. (2017) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2017.01.007 · Cited by 5
Finnberg, N. K., Hart, L. S., Dolloff, N. G., Rodgers, Z. B., Dicker, D. T., & El‐Deiry, W. S. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.028 · Cited by 5
Immune surveillance of nasopharyngeal carcinoma (NpC)
Oluwadara, O., Barkhordarian, A., Giacomelli, L., Brant, X., & Chiappelli, F. (2011) · Bioinformation · doi:10.6026/97320630007271 · Cited by 5
Investigation of tumour environments through advancements in microtechnology and nanotechnology
Liu, Z., Fan, Y. L., Cui, M., Wang, X., & Zhao, P. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117230 · Cited by 4
The Microenvironment in DCIS and Its Role in Disease Progression
Roozitalab, R., Prekete, N., Allen, M. D., Grose, R. P., & Jones, J. L. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-70875-6_12 · Cited by 4
Tucker, J. A., Jochéms, C., Gulley, J. L., Schlom, J., & Tsang, K. Y. (2012) · Cancers · doi:10.3390/cancers4041333 · Cited by 4
Inflammatory Infiltrates in Melanocytic Lesions
Relan, A., Desar, S., Dunnette, B., Shanley, R., & Giubellino, A. (2021) · International Journal of Morphology · doi:10.4067/s0717-95022021000200512 · Cited by 4
Prognostic Value of Innate and Adaptive Immunity in Cancers
Grizzi, F., Caro, G. D., Marchesi, F., & Laghi, L. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_15 · Cited by 4
Immunologic Approaches to Breast Cancer Therapy
Stanton, S. E., Ramos, E., & Disis, M. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35955-9.00071-4 · Cited by 4
Curing tumor-bearing mice by shifting a Th2 to a Th1 anti-tumor response
Hellström, K. E., Dai, M., & Hellström, I. (2017) · Human Antibodies · doi:10.3233/hab-160309 · Cited by 4
Clinical efficacy of anti-CD20 antibodies in autoimmune diseases
Zian, Z., Anka, A. U., Abdullahi, H., Bouallegui, E., Maleknia, S., & Azizi, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19200-5.00016-6 · Cited by 3
Wang, L., Zhou, Y., Cui, H., Zhuang, X., Chen, C., Weng, Y., Liu, H., Wang, S., Pan, X., Cui, Y., et al. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00689-w · Cited by 3
Jiang, Q., Ling, G., Yan, J., Tan, J.-Y., Nong, R.-B., Li, J., Deng, T., Mo, L., & Huang, Q. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101605 · Cited by 3
Wang, W., Zhang, Y., Liu, J., Jing, H., Lu, K., Wang, L., Zhu, T., Xu, Y., Bu, D., Cheng, M., et al. (2023) · World Journal of Surgical Oncology · doi:10.1186/s12957-023-02911-3 · Cited by 3
The Contribution of Immune Cells to Angiogenesis in Inflammation and Tumor Growth
Ribatti, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-68448-2_7 · Cited by 3
Vaccine Immunotherapy Strategies in Colorectal Cancer Treatment
Niccolai, E., & Amedei, A. (2012) · Single Cell Biology · doi:10.4172/2168-9431.1000102 · Cited by 3
Shimabukuro‐Vornhagen, A., Schlößer, H., Stippel, D. L., Theurich, S., & von Bergwelt‐Baildon, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1390052 · Cited by 3
Immunocyte phenotype and breast cancer risk: A Mendel randomization analysis
Li, B., Li, X., Liu, J.-L., Gao, Y., & Li, Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311172 · Cited by 2
Hegyi, B., Csikó, K. G., Balatoni, T., Fröhlich, G., Bőcs, K., Tóth, E., Mohos, A., Neumark, A. R., Menyhárt, C. D., Ferrone, S., et al. (2024) · Biomolecules · doi:10.3390/biom14121609 · Cited by 2
The evolving role of B cells in malignancies
Bindu, S., Bibi, R., Pradeep, R., & Sarkar, K. (2025) · Human Immunology · doi:10.1016/j.humimm.2025.111301 · Cited by 2
Huang, Z., Liu, D., Zhang, Y., Lu, W., Hu, L., Zhang, J., Xie, L., & Chen, S. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1477649 · Cited by 2
Varmazyari, S., Borhani, H., Moradipour, Z., Ziaei, H., & Rezaei, N. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-03176-1_18 · Cited by 2
Leonard, J., Duhamel, M., & Salzet, M. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02902-2 · Cited by 2
Cancer immunotherapy: present scenarios and the future of immunotherapy
Chakraborty, D., Pati, S., Bose, S., Dhar, S., Dutta, S., & Sa, G. (2019) · The Nucleus · doi:10.1007/s13237-019-00273-4 · Cited by 2
Feng, L., Yang, K., Luo, T., & Chen, T. (2025) · Medicine · doi:10.1097/md.0000000000042814 · Cited by 2
Ladke, V. S., Kumbhar, G., Kheur, S. M., & Chougule, H. (2023) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2023.04.003 · Cited by 2
Wang, L., Xu, Z., Zhang, W., Li, L., Liu, X., & Zhang, J. (2023) · iScience · doi:10.1016/j.isci.2023.108661 · Cited by 2
Michal, R., Andrea, W., Halámková, J., Pehalová, L., Řiháčková, E., Bouček, L., Kateřina, K., Hrnčiříková, I., & Kiss, I. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39320 · Cited by 2
Zhang, M., Sun, Q., Yao, Y., Chen, X., Li, J., Yuan, T., Mou, Y., Li, Y., & Song, X. (2025) · Journal of Immunology Research · doi:10.1155/jimr/9375885 · Cited by 2
Autoantibodies and Biomarker Discovery
Qiu, J., & Anderson, K. S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394446-7.00023-6 · Cited by 2
T Cell and Antigen-Presenting Cell Subsets in the Tumor Microenvironment
Wilke, C. M., Wei, S., Wang, L., Kryczek, I., Fang, J., Wang, G., & Zou, W. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4732-0_2 · Cited by 2
Tumor Infiltration by Immune Cells: Pathologic Evaluation and a Clinical Significance
Gutkin, D. W. (2013) · Springer eBooks · doi:10.1007/978-94-007-6217-6_3 · Cited by 2
Sales, M. E. (2012) · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry · doi:10.2174/187152212802001839 · Cited by 2
The Role of the BAFF and Lymphotoxin Pathways in B Cell Biology
Mackay, F., & Gommerman, J. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397933-9.00015-1 · Cited by 2
Sun, S., Wang, Y., Li, M., & Wu, J. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.861380 · Cited by 2
Sherstnev, A. A., & Kovrigina, A. M. (2023) · Clinical oncohematology · doi:10.21320/2500-2139-2023-16-2-109-118 · Cited by 2
Investigating the Effects of Nucleosome Remodeling Factor Knockdown on Anti-Tumor Immunity
Roberts, M. (2016) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/cam4-xc27 · Cited by 2
Single-Cell RNA-Seq Reveals Naïve B cells Associated with Better Prognosis of HCCPreprint
He, J., Lin, Y., Su, X., Luo, Q., Ghazanfar, S., Yang, J. Y. H., & Han, Z. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/731935 · Cited by 2
Comparison of lymphocytic response to oral epithelial pre-neoplastic and inflammatory lesions
Yamamoto, K., Akashi, Y., Nakajima, K., Kokubun, K., Ohno, T., & Matsuzaka, K. (2025) · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · doi:10.1016/j.ajoms.2025.09.013 · Cited by 1
Cheng, S., Tang, J., Mo, Y., & Wu, N. (2025) · Discover Oncology · doi:10.1007/s12672-025-04236-x · Cited by 1
Weeda, Y. A., Salgado, R., Herpe, F. V., Sur, D. G., Vieth, M., Loi, S., Tafti, A. P., Hardas, A., Hida, A. I., Bhalla, A., et al. (2026) · Histopathology · doi:10.1111/his.70089 · Cited by 1
T-cell immune monitoring assays to guide the development of new cancer vaccines
Britten, C. M., Janetzki, S., Gouttefangeas, C., Welters, M. J. P., Kalos, M. D., Ottensmeier, C. H. H., Hoos, A., & van der Burg, S. H. (2011) · Informa Healthcare eBooks · doi:10.3109/9781841848303.012 · Cited by 1
Immune Environment of Cutaneous Malignancies
Ovits, C., & Carucci, J. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-29785-9_42 · Cited by 1
The Role of the BAFF and Lymphotoxin Pathways in B Cell Biology
Mackay, F., & Gommerman, J. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-95895-0.00018-0 · Cited by 1
Quintin‐Colonna, F., Montier, Y., Péré, H., Sandoval, F., Merillon, N., Freyburger, L., Adotévi, O., & Tartour, É. (2009) · Bulletin de l Académie vétérinaire de France · doi:10.4267/2042/48015 · Cited by 1
THE ROLE OF THE IL-17/IL-17R AXIS IN BREAST TUMOR GROWTH AND METASTASIS
Dawod, B. (2016) · DalSpace (Dalhousie University) · Cited by 1
Varela‐Calviño, R. (2015) · World Journal of Immunology · doi:10.5411/wji.v5.i2.68 · Cited by 1
Microenvironment in diffuse large B cell lymphomas
Gualco, G., & Bacchi, C. E. (2015) · doi:10.2217/fmeb2014.14.28 · Cited by 1
Immunotherapy for Precancerous Lesions of the Uterine Cervix
Farghaly, S. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-02701-8_7 · Cited by 1
Inflammatory Cells in Gastric Cancer: Promoting the Tumour or Protecting the Host?
Tone, T., Tauvēna, E., Štrumfa, I., & Gardovskis, J. (2020) · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences · doi:10.2478/prolas-2020-0018 · Cited by 1
Construction of 3D-tumor model for drug screening:Application of microfluidics
Luo, S., Wang, Y., Wang, S., & Chen, A. (2021) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2021-0245 · Cited by 1
Prognostic Value of Innate and Adaptive Immunity in Cancers
Grizzi, F., Borroni, E. M., Yiu, D., Farina, F. M., Cananzi, F., & Laghi, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_19 · Cited by 1
Lin, J., Ran, Y., Wu, T., Wang, Z., Zhao, J., & Tian, Y. (2023) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000497 · Cited by 1
Regulatory B cells: role in the immune response to tumor
Григорьевна, К. З., Ивановна, Ч. А., Анатольевна, Б. А., & Заботина, Т. Н. (2025) · Immunologiya · doi:10.33029/1816-2134-2025-46-1-62-72 · Cited by 1
Novitasari, N., Mulyadi, K., & Maker, L. P. I. I. (2018) · Majalah Patologi Indonesia · Cited by 1
Ersoy, B. (2015) · The Sydney eScholarship Repository (The University of Sydney) · Cited by 1
Markel, J. (2020) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.7770 · Cited by 1
Ebinumoliseh, I., Bijukumar, G., Hoff, K., Brayer, K. J., Bearer, E. L., Ness, S. A., & Edwards, J. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.01.673548 · Cited by 1
Nanoparticle Mediated Chemo-Immunotherapy in Triple-Negative Breast Cancer
Liu, Y. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/czkt-eb93 · Cited by 1
Prognostic markers in oral squamous cell carcinoma
Rikardsen, O. (2014) · NORA - Norwegian Open Research Archives
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
Koo, S., Loh, K. W. J., Kamis, S., Iqbal, J., Dent, R. A., & Sim, Y. Y. (2015) · Current Breast Cancer Reports · doi:10.1007/s12609-015-0196-x
Deconvolution of immunome and degradome repertoires using computational proteomics
Bonissone, S. R. (2015) · eScholarship (California Digital Library)
D'Almeida, S. M. (2015) · theses.fr (ABES) · doi:10.70675/92b9d3a7zb03dz4e4ezae4cz12285759bf0b
Weir, G. M. (2016) · DalSpace (Dalhousie University)
Die Rolle von regulatorischen T-Zellen bei Tumorerkrankungen
Juricke, M. (2015) · MACAU: Open Access Repository of Kiel University (University Library Kiel)
The Omental Fat Band as an Immunomodulatory Microenvironment for Ovarian Cancer
Cohen, C. A. (2013) · VTechWorks (Virginia Tech)
Zatezalo, N. (2017) · DalSpace (Dalhousie University)
Woo, S. (2015) · eScholarship (California Digital Library)
Immunochistochemical Characteristic of the Microenvironment in Squamous Cell Lung Cancer
Баударбекова, М. М., & Kalmykova, A. V. (2017) · Pathologia · doi:10.14739/2310-1237.2017.2.109266
Exploring circulating biomarkers in patients with hepatocellular cancer
Ogle, L. F. (2017)
Josahkian, J. A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2016.tde-21072016-151516
Role of Mesenchymal Stromal Cells in High-Grade Serous Ovarian Cancer
Opinato, V. M. (2018) · ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/)
Phenotypic and molecular characterisation of breast ductal carcinoma in situ
Miligy, I. M. (2019) · Nottingham ePrints (University of Nottingham)
Células B regulatórias: caracterização geral e evidências de sua atuação na imunidade tumoral
Degasperi, G. R., Souza, R. S. X. D., Guidotti, N. C., Borré, G. B., Barbieri, V., Basílio, M. D. A., & Corrêa, J. R. (2020) · Research Society and Development · doi:10.33448/rsd-v9i2.2142
Discovery of novel therapeutic antibodies and targets using tumor-infiltrating B cells
Philippi, M. (2020) · Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG)) · doi:10.24355/dbbs.084-202005181404-0
Suriany, Delyuzar, Alferally, T. I., Joko, A., & Soekimin, S. L. (2020) · International Journal of Scientific and Research Publications · doi:10.29322/ijsrp.10.08.2020.p10457
Hepatobiliary Cancers and Immunology
Kodama, T., & Takehara, T. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_31
Biologia de Sistemas de RNAs Não-Codificadores Longos na Vacinação
de Lima, D. S. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2020.tde-04122020-004322
Cancer Immunology and Immuno-Oncology (Innate vs. Adaptive Cell Immunity)
Nezami, N., Sanchez, C. J., Moon, J. T., Shaikh, J., & Kokabi, N. (2020) · Digestive Disease Interventions · doi:10.1055/s-0040-1721799
Wang, R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.13.431065
Nasri, R., Kouchkar, A., Ladjeround, A., Kaidi, R., Mimoune, N., Boulares, H. A., & Oumouna, M. (2021) · University of Zagreb University Computing Centre (SRCE)
Zhang, X., He, X., Xiong, L., Xu, Y., Chen, W., Liu, X., Hu, X., & Xu, X. (2021) · Research Square · doi:10.21203/rs.3.rs-757554/v1
Killer B Cells: Regulation of the Growth and Function of Fas Ligand-Expressing B Lymphocytes.
Klinker, M. W. (2013) · Deep Blue (University of Michigan)
NOGマウスを用いたpatient-derived xenograft(PDX)モデルにおけるヒト移植組織中リンパ球がモデル樹立に及ぼす影響
藤井, 悦. (2016) · Institutional Repositories DataBase (IRDB) · doi:10.15083/00074995
Development of Antitumor Cellular Immunity
Welters, M. J. P., & van der Burg, S. H. (2013) · Springer eBooks · doi:10.1007/978-94-007-6217-6_5
Tan, L., Bai, X., & Li, D. (1997) · PubMed
B Cells in Cancer Immunology: For or Against Cancer Growth?
Li, Q., Pan, Q., Tao, H., Zhang, X., Huang, S., & Chang, A. E. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_4
B-Cells in Cancer Immunology: For or Against Cancer Growth?
Li, Q., Pan, Q., Tao, H., Zhang, X., Huang, S., & Chang, A. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_4
Metadata
- Authors
- Nelson, B. H.
- Affiliations
- BC Cancer Agency (CA)
- Corresponding author
- Nelson, Brad H
- ORCID
- Nelson, Brad H
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-11-01
- Volume
- 185
- Issue
- 9
- Pages
- 4977-4982
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2107894271
- Semantic Scholar
- bf7939d1d9b47655a2abef372b8ceeacdc5af79b
- Cited by
- 416
- References
- 96
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 20 · 2023: 27 · 2022: 26 · 2021: 25 · 2020: 47 · 2019: 35 · 2018: 30 · 2017: 23 · 2016: 36 · 2015: 30 · 2014: 31 · 2013: 24 · 2012: 17
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- CD20+ B cells, tumor-infiltrating lymphocytes, tertiary lymphoid structures, tumor microenvironment, autoimmunity, organ transplantation, antigen presentation, chemokines, cytokines, tumor immunology
- MeSH terms
- Animals, B-Lymphocytes, Humans, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Autoimmunity, B-Lymphocyte Subsets, Lymphocytes, Tumor-Infiltrating, Antigens, CD20
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.